Get the Stockscreener App
36.36
1.31%
0.47
Vericel Corp stock is traded at $36.36, with a volume of 331.11K.
It is up +1.31% in the last 24 hours and down -8.78% over the past month.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$35.89
Open:
$35.97
24h Volume:
331.11K
Relative Volume:
0.62
Market Cap:
$1.83B
Revenue:
$226.84M
Net Income/Loss:
$3.55M
P/E Ratio:
519.43
EPS:
0.07
Net Cash Flow:
$-12.02M
1W Performance:
-1.81%
1M Performance:
-8.78%
6M Performance:
-26.72%
1Y Performance:
-29.47%
1-Day Range:
$35.84
$36.81
1-Week Range:
$35.18
$37.17
52-Week Range:
$33.09
$63.00
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
36.36 | 1.81B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
What earnings revisions data tells us about Vericel CorporationEarnings Miss & Technical Entry and Exit Alerts - Newser
Pattern recognition hints at Vericel Corporation upsideWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - Newser
Using data tools to time your Vericel Corporation exitMarket Performance Report & Daily Market Momentum Tracking - Newser
Will Vericel Corporation bounce back from current supportQuarterly Profit Summary & Long-Term Capital Growth Ideas - Newser
Backtesting results for Vericel Corporation trading strategiesStop Loss & Long-Term Safe Investment Ideas - Newser
Is this a good reentry point in Vericel CorporationEarnings Recap Report & AI Based Buy and Sell Signals - Newser
Is Vericel Corporation stock ready for a breakoutTrend Reversal & Accurate Intraday Trade Tips - Newser
Is Vericel Corporation forming a bottoming base2025 Breakouts & Breakdowns & Precise Buy Zone Tips - Newser
Will a bounce in Vericel Corporation offer an exitQuarterly Growth Report & Daily Oversold Stock Bounce Ideas - Newser
Analyzing Vericel Corporation with risk reward ratio chartsWall Street Watch & Low Drawdown Trading Strategies - Newser
Is Vericel Corporation stock bottoming outJuly 2025 Sector Moves & High Win Rate Trade Tips - Newser
Using fundamentals and technicals on Vericel CorporationJobs Report & AI Driven Stock Reports - Newser
Statistical indicators supporting Vericel Corporation’s strength2025 Market Overview & Precise Buy Zone Tips - Newser
Volume Profile Shows Strong Base for Vericel Corporation2025 Winners & Losers & Community Shared Stock Ideas - beatles.ru
Published on: 2025-08-29 21:25:24 - Newser
Live market analysis of Vericel CorporationMarket Risk Analysis & Accurate Entry and Exit Point Alerts - Newser
Published on: 2025-08-29 18:53:20 - Newser
Institutional Tools Highlight Unusual Flow in Vericel Corporation getLinesFromResByArray error: size == 0 - sisain.net
What MACD and RSI say about Vericel CorporationProfit Target & AI Based Trade Execution Alerts - Newser
Leading Sports Medicine & Burn Care Biotech Vericel to Present at Wells Fargo Healthcare Conference - Stock Titan
Published on: 2025-08-28 02:46:03 - Newser
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):